Did IBM overhype Watson Health's AI promise?
In recent weeks, IBM has changed leadership at its Watson Health division and announced a new business strategy for deployment that relies on a hybrid cloud, not a public- or private-cloud only model.
Over the past year, Watson Health – particularly Watson for Oncology – has come in for criticism that it has underperformed expectations. (Watson for Oncology is IBM's commercial cognitive computing cloud platform that analyzes large volumes of patient healthcare data and published medical studies to offer physicians cancer treatment options.)